Latest News about CHRS
Recent news which mentions CHRS
From Benzinga
From Benzinga
Coherus BioSciences' Q4 Sales Fall 34% On Lower Udenyca Volume, Prices
February 18, 2022
From Benzinga
Coherus BioSciences (CHRS) Q4 2021 Earnings Call Transcript
February 18, 2022
Tickers
CHRS
From Motley Fool
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
Wall Street analysts’ favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors
December 31, 2021
From MarketWatch
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 20, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 15, 2021
From Benzinga
Coherus BioSciences, inc (CHRS) Q3 2021 Earnings Call Transcript
November 08, 2021
Tickers
CHRS
From Motley Fool
Coherus' Udenyca Body Injector At par With Pre-filled syringe
October 05, 2021
Tickers
CHRS
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
August 19, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 19, 2021
From Benzinga
From Benzinga
From InvestorPlace
21 Stocks Moving in Thursday's Pre-Market Session
August 19, 2021
From Benzinga
Junshi Biosciences, Coherus Receive FDA Breakthrough Therapy Status For Toripalimab In Head & Neck Cancer
August 12, 2021
Tickers
CHRS
From Benzinga
Coherus BioSciences, inc (CHRS) Q2 2021 Earnings Call Transcript
August 06, 2021
Tickers
CHRS
From Motley Fool
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.